Lloyd Advisory Services’s ResMed RMD Stock Holding History

Lloyd Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$3.37K	–	1008
2025 Q4	$3.37K	Buy	+14	New	+$3.58K	﹤0.01%	430
2023 Q4	–	Sell	-1,736	Closed	-$257K	–	296
2023 Q3	$257K	Buy	+1,736	New	+$314K	0.08%	202

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lloyd Advisory Services's RMD Position: Q1 2026 in Review

Lloyd Advisory Services sold out of ResMed (RMD) in Q1 2026, closing a stake of 14 shares — an estimated $3.37K sold.

Lloyd Advisory Services first reported a position in RMD in Q3 2023 and held it in 2 quarters. The position peaked at $257K in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Lloyd Advisory Services reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Lloyd Advisory Services sold 14 ResMed shares in Q1 2026, an estimated $3.37K.
Lloyd Advisory Services first reported a position in ResMed in Q3 2023 and held it in 2 quarters.
Lloyd Advisory Services's ResMed position peaked at $257K in Q3 2023.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Lloyd Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.